Publications by authors named "Yu L Ho"

Claim this Profile
P
Population Pharmacokinetics and Exposure-Response Analyses of Momelotinib, Its Active Metabolite (M21), and Total Active Moiety in Myelofibrosis.
Benjamin Rich, Meenakshi Srinivasan, Yu Liu Ho, Sandra A G Visser, Geraldine Ferron-Brady

Clin Pharmacol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Belantamab Mafodotin with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Comprehensive Exposure-Response Analysis of the DREAMM-8 Study.
Patrick Hanafin, Yu Liu Ho, Theodoros Papathanasiou, Giulia Fulci, Neal Sule

Target Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma.
Theodoros Papathanasiou, Josh Kaullen, Kishore Polireddy, Xi Chen, Yu Liu Ho

Clin Pharmacokinet· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Effect of Momelotinib on Cardiac Repolarization: A Thorough QT Study.
Georgios Vlasakakis, Yolanda Alvarez, Timothy Hart, Yu Liu Ho, Catherine Ellis

Clin Pharmacol Drug Dev· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering the Therapeutic Potential of Novel Pentyloxyamide-Based Class I, IIb HDAC Inhibitors against Therapy-Resistant Leukemia.
Fabian Fischer, Julian Schliehe-Diecks, Jia-Wey Tu, Tanja Gangnus, Yu Lin Ho, Nadine Horstick, Holger Gohlke, Thomas Kurz

J Med Chem· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Momelotinib: Mechanism of action, clinical, and translational science.
Georgios Vlasakakis, Michael T McCabe, Yu Liu Ho, Geraldine Ferron-Brady, Paul Martin

Clin Transl Sci· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical assessment of momelotinib drug-drug interactions via CYP3A metabolism and transporters.
Yu Liu Ho, Pete Gorycki, Geraldine Ferron-Brady, Paul Martin, Georgios Vlasakakis

Clin Transl Sci· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the influence exerted by different dental specialty backgrounds and measuring instrument reproducibility on esthetic aspects of maxillary implant-supported single crown.
Samriddhi Vaidya, Yu Lau Elaine Ho, Jie Hao, Niklaus P Lang, Nikos Mattheos

Clin Oral Implants Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of free fatty acids, safety, and pharmacokinetics of oral GS-9667, an A(1) adenosine receptor partial agonist.
Peter M Staehr, Arvinder K Dhalla, Julia Zack, Xuegong Wang, Yu L Ho

J Clin Pharmacol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis